Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Matching placebo identical to PTT-121 formulation but without the active pharmaceutical ingredient”In the company’s words, NCT07768176 on ClinicalTrials.gov
- Main trialPhase 1
- “This is a Phase I, single-center, randomized, double-blind, placebo-controlled SAD/MAD study to evaluate safety, tolerability, and PK of Intravenously Administered PTT-121 in healthy Chinese adults.”In the company’s words, NCT07768176 on ClinicalTrials.gov
Coming up1
- 31 Aug 2027Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | 31 Aug 2027 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PTT-121 |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026